Sun Pharmaceutical Industries Limited (BOM:524715)
India · Delayed Price · Currency is INR 1,837.15
+13.15 (0.72%)
At close: Jun 19, 2026
BOM:524715 Stock Forecast
Stock Price Forecast
According to 34 analysts polled by S&P Global, BOM:524715 stock has a consensus rating of "Buy" and an average price target of ₹2,047. The average 1-year stock price forecast is 11.44% higher than the current stock price, while the lowest is ₹1,650 (-10.19%) and the highest is ₹2,366 (+28.79%).
Price Target: ₹2,047 (+11.44%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BOM:524715 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 22 | 24 | 23 | 22 | 20 | 20 |
| Buy | 11 | 9 | 9 | 7 | 10 | 10 |
| Hold | 1 | 0 | 0 | 0 | 1 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Total | 38 | 37 | 36 | 32 | 34 | 34 |
Financial Forecast
Revenue This Year
654.29B
from 584.62B
Increased by 11.92%
Revenue Next Year
729.24B
from 654.29B
Increased by 11.46%
EPS This Year
55.04
from 52.01
Increased by 5.82%
EPS Next Year
64.67
from 55.04
Increased by 17.49%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 705.1B | ||
| Avg | 654.3B | ||
| Low | 635.0B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 20.6% | ||
| Avg | 11.9% | ||
| Low | 8.6% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 62.10 | ||
| Avg | 55.04 | ||
| Low | 40.40 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 19.4% | ||
| Avg | 5.8% | ||
| Low | -22.3% |